These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 15013107

  • 1. Insulin-like growth factor-I diminishes the activation status and expression of the small GTPase Cdc42 in articular chondrocytes.
    Fortier LA, Deak MM, Semevolos SA, Cerione RA.
    J Orthop Res; 2004 Mar; 22(2):436-45. PubMed ID: 15013107
    [Abstract] [Full Text] [Related]

  • 2. Gene expression of single articular chondrocytes.
    Eleswarapu SV, Leipzig ND, Athanasiou KA.
    Cell Tissue Res; 2007 Jan; 327(1):43-54. PubMed ID: 16944207
    [Abstract] [Full Text] [Related]

  • 3. The small GTPase Rho mediates articular chondrocyte phenotype and morphology in response to interleukin-1alpha and insulin-like growth factor-I.
    Novakofski K, Boehm A, Fortier L.
    J Orthop Res; 2009 Jan; 27(1):58-64. PubMed ID: 18634065
    [Abstract] [Full Text] [Related]

  • 4. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways.
    Séguin CA, Bernier SM.
    J Cell Physiol; 2003 Dec; 197(3):356-69. PubMed ID: 14566965
    [Abstract] [Full Text] [Related]

  • 5. Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes.
    Boehm AK, Seth M, Mayr KG, Fortier LA.
    Arthritis Rheum; 2007 Jul; 56(7):2335-43. PubMed ID: 17599753
    [Abstract] [Full Text] [Related]

  • 6. Coordinate upregulation of cartilage matrix synthesis in fibrin cultures supplemented with exogenous insulin-like growth factor-I.
    Fortier LA, Lust G, Mohammed HO, Nixon AJ.
    J Orthop Res; 1999 Jul; 17(4):467-74. PubMed ID: 10459751
    [Abstract] [Full Text] [Related]

  • 7. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2.
    Shakibaei M, Seifarth C, John T, Rahmanzadeh M, Mobasheri A.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1382-95. PubMed ID: 17010943
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
    Kaiser M, Haag J, Söder S, Bau B, Aigner T.
    Arthritis Rheum; 2004 Nov 30; 50(11):3535-40. PubMed ID: 15529348
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of the Notch pathway in the regulation of matrix metalloproteinase 13 and the dedifferentiation of articular chondrocytes in murine cartilage.
    Blaise R, Mahjoub M, Salvat C, Barbe U, Brou C, Corvol MT, Savouret JF, Rannou F, Berenbaum F, Bausero P.
    Arthritis Rheum; 2009 Feb 30; 60(2):428-39. PubMed ID: 19180482
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, Weichhart T, Saemann M, Smolen JS.
    Arthritis Rheum; 2007 Jun 30; 56(6):1880-93. PubMed ID: 17530716
    [Abstract] [Full Text] [Related]

  • 16. [Pro-apoptotic effect of retinoic acid on chondrocyte through regulation on gene expression of IGF-2].
    Guo L, Zhan Y, Zhang S, Liu K, Gao X.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb 30; 22(2):217-20. PubMed ID: 18365622
    [Abstract] [Full Text] [Related]

  • 17. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist.
    Johnson K, Farley D, Hu SI, Terkeltaub R.
    Arthritis Rheum; 2003 May 30; 48(5):1302-14. PubMed ID: 12746903
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.